The Joint Transnational Call for Proposals 2021 (JTC 2021) co-funded by the European Commission/DG Research and Innovation on: "Next generation cancer immunotherapy: targeting the tumour microenvironment" will be launched in April 2021.
The ERA-NET TRANSCAN-3, in continuity of the preceding ERA-NET TRANSCAN-2, has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research. The specific challenge is to promote a transnational collaborative approach between scientific teams in demanding areas of translational cancer research while avoiding the duplication of efforts and ensuring a more efficient use of available resources, to produce significant results of higher quality and impact, and share data and infrastructures.
The European Commission (EC) will contribute to the call in accordance with the ERA-NET Cofund scheme.
The call will be published simultaneously by the funding organisations in their respective countries and on the TRANSCAN website: http://www.transcanfp7.eu.
TRANSCAN-3 JTC 2021 will be implemented through a two-stage submission procedure: pre-proposals and full proposals.
The call is planned to be launched on April 6th 2021 with a submission deadline for preproposals on end of June 2021. It is expected that consortia invited for the full-proposal stage will be asked to submit their proposal on November 2021.
Interested researchers and/or research teams are advised to prepare and make the necessary contacts and arrangements towards preparing applications.
For more information: transcanfp7.eu/index.php/news